跳至主要内容
临床试验/EUCTR2017-004866-86-FR
EUCTR2017-004866-86-FR进行中(未招募)1 期

Evaluation of the benefit of adjuvant treatment with hydroxychloroquine to usual medical care for uncomplicated term pregnancy in patients with primary obstetrical antiphospholipid syndrome: randomized, double-blind, placebo-controlled phase II study. HYDROSAPL study - HYDROSAP

ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)0 个研究点目标入组 110 人开始时间: 2020年12月3日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
110

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • - Woman aged = to 18 years
  • - Obstetric SAPL (modified Sapporo criteria = Sydney criteria) defined as fetal death =10 weeks of amenorrhea without further explanation; and / or preeclampsia (or HELLP syndrome) and / or prematurity <34SA related to placental insufficiency with or without thrombotic SAPL
  • - Spontaneous pregnancy in progress before 14 SA
  • - Ability to give informed, written, dated and signed consent prior to the commencement of any trial-related procedure and to comply with protocol recommendations
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 110
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - Other SAPL subgroups: early isolated miscarriage <10 SA
  • - Minor patient
  • - Not affiliated to a social security scheme
  • - Contraindication to hydroxychloroquine
  • o retinopathies,
  • o hypersensitivity to chloroquine or hydroxychloroquine or to any of the other ingredients of this medication, including lactose
  • - Systemic systemic lupus, associated Sjogren syndrome
  • - Hydroxychloroquine treatment in progress
  • - Patient under guardianship or curatorship
  • - Patient deprived of liberty

研究者

相似试验

Evaluation of the benefit of using... | 临床试验